A Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in Chinese Population

Name: A Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in Chinese Population
Published: 2021
License: Public Domain

Sinotau Pharmaceutical Group · 2021

ClinicalTrials.gov · Datasets · License: Public Domain · 2021

Open Source ↗

alzheimer-disease dementia mental-disorders neurodegenerative-diseases

alzheimer disease, dementia, brain diseases, central nervous system diseases, nervous system diseases, tauopathies, neurodegenerative diseases, neurocognitive disorders, mental disorders, florbetaben, amyloid beta-protein, interventional

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in Chinese Population

Related documents